09:38 EDT Catalyst Biosciences Inc trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GYRE:
- Catalyst Biosciences Inc trading halted, volatility trading pause
- Gyre Therapeutics reports Q4 EPS 0c vs. ($1.39) last year
- Gyre Therapeutics initiated with an Outperform at Noble Capital
- Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects
- Five new option listings and option delistings on January 21st
Questions or Comments about the article? Write to editor@tipranks.com